Serum proteomic abnormality predating screen detection of ovarian cancer

Computer Journal

Volumn 52, Issue 3, 2009, Pages 326-333

  Gammerman, Alex ^a,b   Vovk, Volodya ^a   Burford, Brian ^a   Nouretdinov, Ilia ^a   Luo, Zhiyuan ^a   Chervonenkis, Alexey ^a   Waterfield, Mike ^b   Cramer, Rainer ^b,c   Tempst, Paul ^d   Villanueva, Josep ^d   Kabir, Musarat ^b   Camuzeaux, Stephane ^b   Timms, John ^b   Menon, Usha ^b   Jacobs, Ian ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF READING   (United Kingdom)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bioinformatics; Biomarkers; CA125; Human serum proteome; Mass spectra; Ovarian cancer

Indexed keywords

BATCH EXTRACTIONS; CA125; CASE-CONTROL STUDIES; EARLY DETECTIONS; EXPLORATORY ANALYSIS; HEALTHY CONTROLS; HUMAN SERUM PROTEOME; LOW MOLECULAR WEIGHTS; MALDI-TOF MS; MASS SPECTRA; OVARIAN CANCER; OVERALL SURVIVALS; PREFRACTIONATION; PROTEOME; RANDOMIZED CONTROLLED TRIALS; REVERSED-PHASE; SERUM SAMPLES; SINGLE PEAKS; STORAGE CONDITIONS; UNIQUE FEATURES;

BIOINFORMATICS; DIAGNOSIS; MASS SPECTROMETERS; MASS SPECTROMETRY;

BODY FLUIDS;

EID: 65549161444     PISSN: 00104620     EISSN: 14602067     Source Type: Journal    
DOI: 10.1093/comjnl/bxn021     Document Type: Article

References (13)

1. Diamandis, E.P. (2006) Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: Next steps. Cancer Res., 66, 5540-5541.
2. Engwegen, J.Y., Gast, M.C., Schellens, J.H. and Beijnen, J.H. (2006) Clinical proteomics: Searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol. Sci., 27, 251-259.
3. Xiao, Z., Prieto, D., Conrads, T.P., Veenstra, T.D. and Issaq, H.J. (2005) Proteomic patterns: Their potential for disease diagnosis. Mol. Cell. Endocrinol., 230, 95-106.
4. Ozols, R.F., Rubin, S.C., Thomas, G.M. and Robboy, S.J. (2005) Epithelial ovarian cancer. In Hoskins, W.J., Perez, C.A. and Young, R.C. (eds), Principles and Practice of Gynecologic Oncology (4th edn), pp. 823-872. Lippincott Williams & Wilkins, Philadelphia.
5. Menon, U. (2007) Ovarian cancer: Challenges of early detection. Nat. Clin. Pract. Oncol., 4, 498-499.
6. Menon, U. et al. (2005) Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J. Clin. Oncol., 23, 7919-7926.
7. Timms, J.F. et al. (2007) Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. Clin. Chem., 53, 645-656.
8. Koomen, J.M., Shih, L.N., Coombes, K.R., Li, D., Xiao, L.-c., Fidler, I.J., Abbruzzese, J.L. and Kobayashi, R. (2005) Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin. Cancer. Res., 11, 1110-1118.
9. Zhang, Z. et al. (2004) Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res., 64, 5882-5890.
10. Song, J., Patel, M., Rosenzweig, C.N., Chan-Li, Y., Sokoll, L.J., Fung, E.T., Choi-Miura, N.-H., Goggins, M., Chan, D.W. and Zhang, Z. (2006) Quantification of fragments of human serum inter-α-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay. Clin. Chem., 52, 1045-1053.
11. Villanueva, J. et al. (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest., 116, 271-284.
12. Villanueva, J., Philip, J., Entenberg, D., Chaparro, C.A., Tanwar, M.K., Holland, E.C. and Tempst, P. (2004) Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem., 76, 1560-1570.
13. Villanueva, J., Lawlor, K., Toledo-Crow, R. and Tempst, P. (2006) Automated serum peptide profiling. Nat. Protoc., 1, 880-891.